132 related articles for article (PubMed ID: 1648095)
1. Monoclonal anti-idiotypic antibodies to platelet activating factor (PAF) and their interaction with PAF receptors.
Wang CJ; Tai HH
J Biol Chem; 1991 Jul; 266(19):12372-8. PubMed ID: 1648095
[TBL] [Abstract][Full Text] [Related]
2. Internal image properties of a monoclonal auto-anti-idiotypic antibody and its binding to aldosterone receptors.
Lombes M; Edelman IS; Erlanger BF
J Biol Chem; 1989 Feb; 264(5):2528-36. PubMed ID: 2521629
[TBL] [Abstract][Full Text] [Related]
3. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.
Paulson SK; Wolf JL; Novotney-Barry A; Cox CP
Proc Soc Exp Biol Med; 1990 Nov; 195(2):247-54. PubMed ID: 2172997
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
Hwang SB; Lam MH; Chang MN
J Biol Chem; 1986 Oct; 261(29):13720-6. PubMed ID: 3020044
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-idiotypic antibody to a potent thromboxane A2 receptor antagonist and its interaction with thromboxane A2 receptor.
Kan WM; Tai HH
J Biol Chem; 1993 Mar; 268(9):6364-70. PubMed ID: 8454607
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
9. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
10. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
11. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.
Hwang SB; Lam MH; Pong SS
J Biol Chem; 1986 Jan; 261(2):532-7. PubMed ID: 3001070
[TBL] [Abstract][Full Text] [Related]
12. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
Kudolo GB; Harper MJ
Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
[TBL] [Abstract][Full Text] [Related]
14. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
15. PAF binding to a single receptor in corneal epithelium plasma membrane.
Hurst J; Ma X; Bazan HE
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
[TBL] [Abstract][Full Text] [Related]
16. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding.
Mikashima H; Takehara S; Muramoto Y; Khomaru T; Terasawa M; Tahara T; Maruyama Y
Jpn J Pharmacol; 1987 Aug; 44(4):387-91. PubMed ID: 2890779
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
[TBL] [Abstract][Full Text] [Related]
19. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes.
Chau LY; Tsai YM; Cheng JR
Biochem Biophys Res Commun; 1989 Jun; 161(3):1070-6. PubMed ID: 2545193
[TBL] [Abstract][Full Text] [Related]
20. An anti-platelet activating factor antibody and its effects on platelet aggregation.
Tatsumi N; Terano Y; Hashimoto K; Hiyoshi M; Matsuura S
Osaka City Med J; 1993 Nov; 39(2):167-74. PubMed ID: 8183536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
